Beyond Length of Stay and 30-Day Readmission: Assessing the Value of Addiction Consultation Services - Summary - MDSpire

Evaluating the Impact of Addiction Consultation Services Beyond Hospital Stay Duration and 30-Day Readmission Rates

  • By

  • Jarratt D. Pytell

  • Susan L. Calcaterra

  • July 16, 2026

Share

Objective:

To assess the impact of addiction consultation services (ACS) on hospital stay duration, 30-day readmission rates, and other patient outcomes.

Approach:
  • Study Design: Retrospective study using a difference-in-differences approach comparing outcomes at one hospital with ACS implementation to three hospitals without ACS.
Key Findings:
  • ACS implementation did not affect length of stay or 30-day readmission rates.
  • ACS was associated with higher rates of medications for opioid use disorder during hospitalization and discharge on higher methadone doses.
  • ACS implementation did not impact 6-month emergency department visits or patient-directed discharge.
  • The economic rationale for ACS implementation may be questioned based on findings of no change in length of stay or readmission rates.
Interpretation:

The outcomes most visible to health system leaders may not reflect the quality of care provided by ACS.

Limitations:
  • Length of stay and 30-day readmission rates may not adequately capture the value of ACS.
  • The study did not report on postdischarge addiction treatment linkage.
Conclusion:

The value of ACS depends on various factors, including hospital context and community substance use disorder prevalence.

Sources:

Original Source(s)

Related Content